Fund Holdings — Foresite Capital Management IV, LLC

Total Portfolio Value:
$153.01M
Total Bought:
$7.80M
Total Sold:
$0
Net Transaction:
+$7.80M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Pharvaris N.V.
COM
4,293,8544,397,881+104,027$80.72M$81.45M53.23%+$724.3K
Kura Oncology, Inc.(KURA)1,849,9471,849,9470$38.09M$36.15M23.62%-$1.94M
Syndax Pharmaceuticals, Inc.(SNDX)875,000875,0000$17.96M$16.84M11.01%-$1.12M
Lyell Immunopharma, Inc.(LYEL)8,325,0008,325,0000$12.07M$11.49M7.51%-$582.8K
Relay Therapeutics, Inc.(RLAY)01,000,000+1,000,000$0$7.08M4.63%+$7.08M
Page 1 of 1
Foresite Capital Management IV, LLC — 13F Holdings — Q3 2024 | TickerTrail